NO328863B1 - Farmasoytisk preparat for oral administrering inneholdende omeprazol - Google Patents

Farmasoytisk preparat for oral administrering inneholdende omeprazol Download PDF

Info

Publication number
NO328863B1
NO328863B1 NO20014074A NO20014074A NO328863B1 NO 328863 B1 NO328863 B1 NO 328863B1 NO 20014074 A NO20014074 A NO 20014074A NO 20014074 A NO20014074 A NO 20014074A NO 328863 B1 NO328863 B1 NO 328863B1
Authority
NO
Norway
Prior art keywords
preparation according
weight
percent
liquid carrier
fatty acids
Prior art date
Application number
NO20014074A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014074L (no
NO20014074D0 (no
Inventor
Keith Freehauf
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of NO20014074L publication Critical patent/NO20014074L/no
Publication of NO20014074D0 publication Critical patent/NO20014074D0/no
Publication of NO328863B1 publication Critical patent/NO328863B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20014074A 1999-02-23 2001-08-22 Farmasoytisk preparat for oral administrering inneholdende omeprazol NO328863B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12125399P 1999-02-23 1999-02-23
PCT/US2000/004170 WO2000050038A1 (en) 1999-02-23 2000-02-18 Pharmaceutical composition containing proton pump inhibitors

Publications (3)

Publication Number Publication Date
NO20014074L NO20014074L (no) 2001-08-22
NO20014074D0 NO20014074D0 (no) 2001-08-22
NO328863B1 true NO328863B1 (no) 2010-05-31

Family

ID=22395498

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014074A NO328863B1 (no) 1999-02-23 2001-08-22 Farmasoytisk preparat for oral administrering inneholdende omeprazol

Country Status (31)

Country Link
US (1) US6316481B1 (xx)
EP (1) EP1156806B1 (xx)
JP (1) JP2002537337A (xx)
KR (1) KR100701448B1 (xx)
CN (1) CN1227009C (xx)
AR (1) AR029615A1 (xx)
AT (1) ATE263562T1 (xx)
AU (1) AU771061B2 (xx)
BG (1) BG65291B1 (xx)
BR (1) BR0008403A (xx)
CA (1) CA2362932C (xx)
CO (1) CO5140102A1 (xx)
CZ (1) CZ301647B6 (xx)
DE (1) DE60009675T2 (xx)
DK (1) DK1156806T3 (xx)
EA (1) EA004683B1 (xx)
ES (1) ES2216870T3 (xx)
HK (1) HK1041650A1 (xx)
HR (1) HRP20010615B1 (xx)
HU (1) HU228181B1 (xx)
IL (1) IL144131A0 (xx)
ME (1) ME00864B (xx)
NO (1) NO328863B1 (xx)
NZ (1) NZ512771A (xx)
PL (1) PL195783B1 (xx)
PT (1) PT1156806E (xx)
RS (1) RS50023B (xx)
SK (1) SK286371B6 (xx)
TW (1) TW587936B (xx)
WO (1) WO2000050038A1 (xx)
ZA (1) ZA200106104B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
ES2345873T3 (es) * 2000-05-30 2010-10-05 Merial Limited Composiciones para la prevencion de ulceras en caballos.
KR20030059318A (ko) 2000-12-07 2003-07-07 알타나 파마 아게 산 불안정성 활성 성분을 포함하는 현탁액 형태의 약학 제제
AU2002231654A1 (en) 2000-12-07 2002-06-18 Byk Gulden Lomberg Chemische Fabrik G.M.B.H. Pharmaceutical paste comprising an acid-labile active ingredient
DE10061135C1 (de) * 2000-12-07 2002-11-07 Byk Gulden Lomberg Chem Fab Pharmazeutische Zubereitung in Form einer Paste enthaltend einen säurelabilen Wirkstoff
CA2493618A1 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
GB2394895A (en) * 2002-11-06 2004-05-12 Cipla Ltd Proton pump inhibitor composition in paste form
WO2005000269A1 (en) * 2003-06-26 2005-01-06 Cipla Limited Pharmaceutical formulations comprising a proton pump inhibitor
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2006026829A1 (en) * 2004-09-09 2006-03-16 Metelli Pty Ltd Stable paste composition of enteric coated acid labile active agent and use thereof
CN101500553B (zh) * 2006-07-25 2012-04-18 维克塔有限公司 联合使用小分子二羧酸的衍生物与ppi用于抑制胃酸分泌的组合物和方法
CN101610754A (zh) 2007-02-16 2009-12-23 Aska制药株式会社 含有微粒油性混悬液的药物组合物
US8530500B2 (en) 2009-07-20 2013-09-10 Vetegen, Llc Stable pharmaceutical omeprazole formulation for oral administration
WO2012106058A2 (en) 2011-01-31 2012-08-09 New Market Pharmaceuticals Animal treatments
US10064849B2 (en) 2012-05-02 2018-09-04 New Market Pharmaceuticals Pharmaceutical compositions for direct systemic introduction
EP3791866A1 (en) 2012-05-02 2021-03-17 NewMarket Pharmaceuticals LLC Pharmaceutical compositions for direct systemic introduction
GB2524351B (en) * 2013-10-18 2016-12-14 Norbrook Lab Ltd Proton Pump Inhibitor Paste Compositions
ES2717029T3 (es) * 2013-10-18 2019-06-18 Norbrook Lab Ltd Composiciones de pasta inhibidora de la bomba de protones
DK3386507T3 (da) 2015-12-08 2023-09-18 Luoda Pharma Ltd Metoder og sammensætninger til behandling af mavesår
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US10137111B2 (en) 2016-08-11 2018-11-27 Adamis Pharmaceuticals Corporation Drug compositions comprising an anti-parasitic and proton pump inhibitor
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS
ES2723873B1 (es) * 2018-03-01 2020-05-13 Hernan Ma Carmen Batanero Medicamento combinado con omeprazol y vitamina B12
CN112972481A (zh) * 2021-03-18 2021-06-18 华农(肇庆)生物产业技术研究院有限公司 药物组合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255432A (en) 1979-09-06 1981-03-10 Syntex (U.S.A.) Inc. 8-[2-3-Indolyl)ethyl]-1-oxa-3-,8-diazaspiro[4.5]decan-2-ones, pharmaceutical compositions thereof and methods of use thereof
DK130287D0 (da) 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
SE9301489D0 (sv) 1993-04-30 1993-04-30 Ab Astra Veterinary composition
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors

Also Published As

Publication number Publication date
AR029615A1 (es) 2003-07-10
HUP0200325A2 (en) 2002-06-29
WO2000050038A1 (en) 2000-08-31
PL195783B1 (pl) 2007-10-31
ME00864B (me) 2008-09-29
ATE263562T1 (de) 2004-04-15
HUP0200325A3 (en) 2003-05-28
HK1041650A1 (en) 2002-07-19
AU771061B2 (en) 2004-03-11
ZA200106104B (en) 2002-12-24
EP1156806B1 (en) 2004-04-07
CZ20013058A3 (cs) 2001-11-14
SK286371B6 (sk) 2008-08-05
CO5140102A1 (es) 2002-03-22
HRP20010615A2 (en) 2002-12-31
DE60009675D1 (de) 2004-05-13
PT1156806E (pt) 2004-07-30
DE60009675T2 (de) 2005-03-24
BG65291B1 (bg) 2007-12-28
CA2362932A1 (en) 2000-08-31
HU228181B1 (en) 2013-01-28
PL350729A1 (en) 2003-01-27
NO20014074L (no) 2001-08-22
RS50023B (sr) 2008-09-29
HRP20010615B1 (en) 2011-03-31
ES2216870T3 (es) 2004-11-01
IL144131A0 (en) 2002-05-23
KR20010102297A (ko) 2001-11-15
BG105754A (en) 2002-03-29
TW587936B (en) 2004-05-21
AU3368700A (en) 2000-09-14
EA004683B1 (ru) 2004-06-24
NZ512771A (en) 2003-02-28
BR0008403A (pt) 2002-01-29
CN1227009C (zh) 2005-11-16
SK12062001A3 (sk) 2001-12-03
CA2362932C (en) 2010-11-30
EA200100905A1 (ru) 2002-02-28
US6316481B1 (en) 2001-11-13
NO20014074D0 (no) 2001-08-22
JP2002537337A (ja) 2002-11-05
YU50401A (sh) 2004-05-12
EP1156806A1 (en) 2001-11-28
CN1341022A (zh) 2002-03-20
CZ301647B6 (cs) 2010-05-12
DK1156806T3 (da) 2004-08-02
KR100701448B1 (ko) 2007-03-30

Similar Documents

Publication Publication Date Title
NO328863B1 (no) Farmasoytisk preparat for oral administrering inneholdende omeprazol
JP4603631B2 (ja) プロトンポンプ阻害剤を含有する医薬組成物
FI96095C (fi) Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi
WO2006026829A1 (en) Stable paste composition of enteric coated acid labile active agent and use thereof
GB2394895A (en) Proton pump inhibitor composition in paste form
MXPA01008525A (en) Pharmaceutical composition containing proton pump inhibitors
WO2005000269A1 (en) Pharmaceutical formulations comprising a proton pump inhibitor
AU2005100669A4 (en) Enteric coated paste compositions and uses thereof

Legal Events

Date Code Title Description
MK1K Patent expired